Adrenergic Beta Receptor Blockaders

  • Cardiac function and dysfunction in hypertension
    Fetnat M. Fouad, MD
    Cleveland Clinic Journal of Medicine September 1994, 61 (5) 351-355;

    Assessment of systolic and diastolic function is important in the follow-up of hypertensive patients and in the choice of therapy.

  • Labetalol and other agents that block both alpha- and beta-adrenergic receptors
    Donald G. Vidt, MD, Alan Bakst, PharmD, Carolyn J. Pearce, MD and J. David Wallin, MD
    Cleveland Clinic Journal of Medicine January 1994, 61 (1) 59-69;

    A review of how these agents can be used in managing difficult-to-control hypertension.

  • Current hypertension management: separating fact from fiction
    Marvin Moser, MD
    Cleveland Clinic Journal of Medicine January 1993, 60 (1) 27-37;

    Speculations that have led many physicians to abandon the use of diuretics have not proven to be of clinical relevance in most instances.

  • Nontraditional combination pharmacotherapy of hypertension
    James M. Sutton, MD and Susan P. Bagby, MD
    Cleveland Clinic Journal of Medicine September 1992, 59 (5) 459-468;

    Which new combinations hold the most promise for safer, more effective blood pressure control ?

  • Adrenergic agents: clinical trials and experiences
    Alan Bakst, PhannD and Lennart Hansson, MD, PhD
    Cleveland Clinic Journal of Medicine May 1992, 59 (3) 248-254;

    Different beta blockers have different effects on cardiac output and heart rate, and some may diminish detrimental arterial changes induced by hypertension. A long-term preventive effect against coronary artery disease remains to be demonstrated.